Cardlytics (CDLX) Tops Q4 EPS by 28c, Beats on Revenue

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of $0.00, $0.28 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $55.17 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• CNH Industrial (CNH) call put ratio 1 call to 8.3 puts with a focus on 1722 contracts of December 10 puts
• NewAmsterdam Pharma (NAMS) call put ratio 1 call to 4.8 puts with a focus on 2K contracts of January 25 puts